JAK1 inhibition and inflammatory bowel disease

Primary non-response and secondary loss of response remain a significant issue with the currently available treatment options for a significant proportion of patients with inflammatory bowel disease (IBD). There are multiple unmet needs in the IBD treatment algorithm and new treatment options are re...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Clare, Cummings, J R Fraser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098109/
https://www.ncbi.nlm.nih.gov/pubmed/33950226
http://dx.doi.org/10.1093/rheumatology/keaa896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098109/
https://www.ncbi.nlm.nih.gov/pubmed/33950226
http://dx.doi.org/10.1093/rheumatology/keaa896

Ejemplares similares